| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 693248 | Null | 0.043472147060915 | -0.17604464 |
| NSC 694619 | Null | 0.043472147060915 | 0.0062988445 |
| NSC 709974 | Null | 0.043472147060915 | -0.34167652 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.043472147060915 | 0.27663252 |
| NSC 720134 | Null | 0.043472147060915 | -0.15156192 |
| NSC 720495 | Null | 0.043472147060915 | 0.18615631 |
| NSC 734287 | 6-(3-Aminopropyl)-5,6-dihydro-7,8,9-trimethoxy-3-nitro-5,11- dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.043472147060915 | 0.18152885 |
| NSC 734949 | 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide | 0.043472147060915 | 0.075720643 |
| NSC 150311 | 2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- | 0.0446159312763229 | -0.040858344 |
| NSC 155693 | 6H-Pyrido[4,3-b]carbazolium, 9-methoxy-2,5,11-trimethyl-,iodide | 0.0446159312763229 | 0.25865459 |